Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 13/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 13/20 | 0.59 |
| ▸ | BRD4 | O60885 | 13/20 | 0.59 |
| ▸ | BRD2 | P25440 | 10/20 | 0.59 |
| ▸ | BRD3 | Q15059 | 10/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.53 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16619145 | 0.92 | BRD4 (0.54) | CYP3A4CYP2C9BRD4BRD2BRD3 | |
| SCHEMBL16618883 | 0.92 | BRD4 (0.54) | CYP3A4CYP2C9BRD4BRD2BRD3 | |
| SCHEMBL16618982 | 0.89 | BRD4 (0.65) | CYP3A4CYP2C9BRD4BRD2BRD3 | |
| SCHEMBL16619166 | 0.89 | BRD4 (0.53) | CYP3A4CYP2C9BRD4BRD2BRD3 | |
| SCHEMBL16619413 | 0.87 | BRD4 (0.77) | CYP3A4CYP2C9BRD4BRD2BRD3 | |
| SCHEMBL16619446 | 0.85 | CYP3A4 (0.78) | CYP3A4CYP2C9BRD4BRD2BRD3 | |
| SCHEMBL16619839 | 0.85 | BRD4 (0.59) | CYP3A4CYP2C9BRD4BRD2BRD3 | |
| SCHEMBL16619401 | 0.85 | CYP3A4 (0.58) | CYP3A4CYP2C9BRD4BRD2BRD3 | |
| SCHEMBL11909184 | 0.85 | BRD4 (0.59) | CYP3A4CYP2C9BRD4BRD2BRD3 | |
| SCHEMBL16619717 | 0.85 | CYP3A4 (0.52) | CYP3A4CYP2C9BRD4BRD2BRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015049629-A1 | IMIDAZOQUINOLINE COMPOUNDS AS BROMODOMAIN INHIBITORS | Piramal Enterprises Limited (IN) | 2015-04-09 | — | — | WO | disclosed |